OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
237
Results
Show all
Save search
Copy query
Show results for
Unknown
(233)
Genomic
(2)
Proteomics
(1)
Metabolomics
(1)
Repository
dbGaP
(2)
MassIVE
(1)
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
LTQ
(1)
LTQ FT
(1)
LTQ Orbitrap
(1)
LTQ Orbitrap Velos
(1)
6520 Q-TOF LC/MS (Agilent)
(1)
Publication Date
2015
(1)
2016
(1)
Metabolite Name
(+)-.alpha.-tocopherol
(1)
(+)-catechin
(1)
(+)-isocorydine
(1)
(-)-.alpha.-kainic acid
(1)
(-)-epigallocatechin
(1)
(-)-myrtenol
(1)
(2e,4e)-hexa-2,4-dienoic acid
(1)
(2e,4e,12z)-n-(2-methylpropyl)octadeca-2,4,12-trienamide
(1)
(3.beta.,5.alpha.)-4,4-dimethylcholesta-8,14,24-trien-3-ol
(1)
(4r)-4-((1r,3s,5s,7r,9s,10s,12s,13r,14s,17r)-1,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid
(1)
(r)-butyrylcarnitine
(1)
(s)-cotinine n-oxide
(1)
.alpha.-L-Glu-L-Tyr
(1)
.alpha.-ionone
(1)
.beta.-muricholic acid
(1)
.beta.-nicotinamide adenine dinucleotide, reduced(NADH)
(1)
.beta.-sitosterol
(1)
.beta.-thujaplicin
(1)
.delta.-dodecalactone
(1)
.gamma.-aminobutyric acid
(1)
.gamma.-l-glu-.epsilon.-l-lys
(1)
.omega.-3 arachidonic acid
(1)
1,2-di-(9z,12z,15z-octadecatrienoyl)-sn-glycero-3-phosphocholine
(1)
1,2-dilinolenoyl-sn-glycero-3-phosphoethanolamine
(1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n,n-dimethyl
(1)
1,2-dioleoyl-sn-glycerol
(1)
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine
(1)
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine
(1)
1,5-pentanediamine
(1)
Release Date
2025
(34)
2022
(34)
2023
(28)
2021
(26)
2024
(25)
2020
(24)
2018
(17)
2019
(12)
2016
(11)
2015
(10)
2017
(8)
2014
(1)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 24
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
24
Next
page
Sort
by:
Relevance
Page size
10
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation.
Not available
S-EPMC7617617
|
biostudies-literature
Cite
1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial
Not available
S-EPMC7777633
|
biostudies-literature
Cite
Therapeutic interventions targeting enteropathy in severe acute malnutrition modulate systemic and vascular inflammation and epithelial regeneration.
Not available
S-EPMC11697704
|
biostudies-literature
Cite
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer.
Not available
S-EPMC8047034
|
biostudies-literature
Cite
Associations between social support, psychological well-being, decision making, empowerment, infant and young child feeding, and nutritional status in Ugandan children ages 0 to 24 months.
Not available
S-EPMC6866247
|
biostudies-literature
Cite
LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be NonInferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-Naive Adults With HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial
Not available
S-EPMC6253652
|
biostudies-literature
Cite
MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis.
Not available
S-EPMC9038546
|
biostudies-literature
Cite
3D bioprinted white adipose model for
in vitro
study of cancer-associated cachexia induced adipose tissue remodeling.
Not available
S-EPMC9205601
|
biostudies-literature
Cite
Health Outcomes, Pathogenesis and Epidemiology of Severe Acute Malnutrition (HOPE-SAM): rationale and methods of a longitudinal observational study.
Not available
S-EPMC6361330
|
biostudies-literature
Cite
Strategies to Prevent or Reduce Gender Bias in Peer Review of Research Grants: A Rapid Scoping Review.
Not available
S-EPMC5218731
|
biostudies-literature
Cite
Previous
page
1 / 24
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
24
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
